MTOR and cancer: Yothaisong et al. (2013) similarly shown that the combined inhibition of PI3K and mTOR with NVP-BEZ235 significantly decreased cell viability and increased apoptosis in CCA cells, highlighting the cancer’s need on PI3K/Akt/mTOR signalling for survival [41].